The Pfizer-BioNTech BNT162b vaccine was the most frequently associated, inducing GD in 33 cases (44%), followed by ChAdOx1 nCoV-19 (Covishield, AstraZeneca) in 14 cases (18.7%), and Moderna mRNA-1273 in eight cases (10.7%)
The proposed mechanisms by which GLP-1 receptor agonists might influence pancreatic health involve several biological pathways, though none have been conclusively proven to cause pancreatitis in humans
Consistency and proper dosing are key
Bone density loss: While studies are still ongoing as to GLP-1s effect on bone health, bone mineral density could decrease with diet-induced weight loss 8 If your GLP-1 journey has led to any of these adverse effects, we offer support for digestive comfort, filling nutritional gaps, sustained energy, lean muscle building and bone strengthening
Some researchers have explored doses at the initial titration level (for example, 0.25 mg weekly of semaglutide, which is the standard starting dose for Ozempic but subtherapeutic for glycemic control), hypothesizing that anti-inflammatory benefits might be achieved with reduced gastrointestinal side effects